Incidence of heart failure after myocardial infarction: is it changing over time? - PubMed (original) (raw)

. 2003 Jun 15;157(12):1101-7.

doi: 10.1093/aje/kwg078.

Affiliations

• PMID: 12796046
• DOI: 10.1093/aje/kwg078

Incidence of heart failure after myocardial infarction: is it changing over time?

Jens P Hellermann et al. Am J Epidemiol. 2003.

Abstract

Improved survival after myocardial infarction (MI) could result in MI survivors' contributing to the US heart failure epidemic. Conversely, since the severity of MI is declining over time, a decline in post-MI heart failure might also be anticipated. This study tested the hypothesis that the incidence of post-MI heart failure was declining over time in a geographically defined MI incidence cohort. Between 1979 and 1994, 1,537 patients with incident MI and no prior history of heart failure were hospitalized in Olmsted County, Minnesota. Framingham Heart Study criteria were used to ascertain the incidence of inpatient and outpatient heart failure over a mean follow-up period of 7.6 years (standard deviation 5.5). Overall, 36% of patients experienced heart failure. After adjustment for factors related to post-MI heart failure (age, hypertension, smoking, and biomarkers), the incidence of heart failure declined by 2% per year (relative risk = 0.98, 95% confidence interval: 0.96, 0.99; p = 0.01). The relative risk of developing heart failure among persons with MIs occurring in 1994 versus 1979 was 0.72 (95% confidence interval: 0.55, 0.93), indicating a 28% reduction in the incidence of heart failure. Administration of reperfusion therapy within 24 hours after MI was associated with lower risk of post-MI heart failure and accounted for most of the temporal decline in heart failure. This suggests that improved survival after MI is unlikely to be a major contributor to the heart failure epidemic.

PubMed Disclaimer

Similar articles

• Atherosclerotic Burden and Heart Failure After Myocardial Infarction.
  Gerber Y, Weston SA, Enriquez-Sarano M, Manemann SM, Chamberlain AM, Jiang R, Roger VL. Gerber Y, et al. JAMA Cardiol. 2016 May 1;1(2):156-62. doi: 10.1001/jamacardio.2016.0074. JAMA Cardiol. 2016. PMID: 27437886 Free PMC article.
• Mortality Associated With Heart Failure After Myocardial Infarction: A Contemporary Community Perspective.
  Gerber Y, Weston SA, Enriquez-Sarano M, Berardi C, Chamberlain AM, Manemann SM, Jiang R, Dunlay SM, Roger VL. Gerber Y, et al. Circ Heart Fail. 2016 Jan;9(1):e002460. doi: 10.1161/CIRCHEARTFAILURE.115.002460. Epub 2015 Dec 23. Circ Heart Fail. 2016. PMID: 26699392 Free PMC article.
• Long-term trends in the incidence of heart failure after myocardial infarction.
  Velagaleti RS, Pencina MJ, Murabito JM, Wang TJ, Parikh NI, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Velagaleti RS, et al. Circulation. 2008 Nov 11;118(20):2057-62. doi: 10.1161/CIRCULATIONAHA.108.784215. Epub 2008 Oct 27. Circulation. 2008. PMID: 18955667 Free PMC article.
• Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction.
  Cleland JG, Torabi A, Khan NK. Cleland JG, et al. Heart. 2005 May;91 Suppl 2(Suppl 2):ii7-13; discussion ii31, ii43-8. doi: 10.1136/hrt.2005.062026. Heart. 2005. PMID: 15831613 Free PMC article. Review.
• Silent myocardial infarction and risk of heart failure: Current evidence and gaps in knowledge.
  Soliman EZ. Soliman EZ. Trends Cardiovasc Med. 2019 May;29(4):239-244. doi: 10.1016/j.tcm.2018.09.004. Epub 2018 Sep 8. Trends Cardiovasc Med. 2019. PMID: 30224236 Review.

Cited by

• Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction.
  Sopova K, Tual-Chalot S, Mueller-Hennessen M, Vlachogiannis NI, Georgiopoulos G, Biener M, Sachse M, Turchinovich A, Polycarpou-Schwarz M, Spray L, Maneta E, Bennaceur K, Mohammad A, Richardson GD, Gatsiou A, Langer HF, Frey N, Stamatelopoulos K, Heineke J, Duerschmied D, Giannitsis E, Spyridopoulos I, Stellos K. Sopova K, et al. Front Immunol. 2023 Jun 22;14:1177467. doi: 10.3389/fimmu.2023.1177467. eCollection 2023. Front Immunol. 2023. PMID: 37426649 Free PMC article.
• Predictive factors of heart failure in acute coronary syndrome: Institutional cross-sectional study.
  Bachar A, Benmessaoud FA, Diatta A, Fadoum H, Haroun AE, Oukerraj L, Cherti M. Bachar A, et al. Ann Med Surg (Lond). 2022 Aug 10;81:104332. doi: 10.1016/j.amsu.2022.104332. eCollection 2022 Sep. Ann Med Surg (Lond). 2022. PMID: 36147130 Free PMC article.
• Correlation between Traditional Chinese Medicine Syndromes and Type 2 Myocardial Infarction in Critically Ill Patients with Pulmonary Disease.
  Ma SL, Hu SY, Li WL, You DL, Jiang TT, Wang L, Wang F, Wu X. Ma SL, et al. Evid Based Complement Alternat Med. 2022 Mar 21;2022:9329683. doi: 10.1155/2022/9329683. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35356241 Free PMC article.
• A Long-Term Incidence of Heart Failure and Predictors Following Newly Developed Acute Myocardial Infarction: A 10 Years Retrospective Cohort Study with Korean National Health Insurance Data.
  Choi H, Seo JY, Shin J, Choi BY, Kim YM. Choi H, et al. Int J Environ Res Public Health. 2021 Jun 8;18(12):6207. doi: 10.3390/ijerph18126207. Int J Environ Res Public Health. 2021. PMID: 34201267 Free PMC article.
• In-hospital outcome of primary PCI for patients with acute myocardial infarction and prior coronary artery bypass grafting.
  Liu Y, Wang LF, Yang XC, Su PX, Li KB, Wang HS, Chen ML, Xu L, Zhong JC. Liu Y, et al. J Thorac Dis. 2021 Mar;13(3):1737-1745. doi: 10.21037/jtd-20-1813. J Thorac Dis. 2021. PMID: 33841964 Free PMC article.

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems

• Medical

  • MedlinePlus Health Information